176 related articles for article (PubMed ID: 38315652)
1. A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats.
Hassan G; Kamar SA; Rady HY; Abdelrahim DS; Abdel Hay Ibrahim NH; Lasheen NN
PLoS One; 2024; 19(2):e0296187. PubMed ID: 38315652
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
Saroj P; Bansal Y; Singh R; Akhtar A; Sodhi RK; Bishnoi M; Sah SP; Kuhad A
Inflammopharmacology; 2021 Apr; 29(2):499-511. PubMed ID: 33517508
[TBL] [Abstract][Full Text] [Related]
3. Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.
Feng H; Wang C; He W; Wu X; Li S; Zeng Z; Wei M; He B
Metab Brain Dis; 2019 Apr; 34(2):583-591. PubMed ID: 30610438
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
Jabaris SS; Sumathy H; Girish R; Narayanan S; Sugumar M; Saravana Babu C; Thanikachalam S; Thanikachalam M
Brain Res; 2015 Oct; 1622():279-91. PubMed ID: 26168894
[TBL] [Abstract][Full Text] [Related]
5. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
[TBL] [Abstract][Full Text] [Related]
6. Roflumilast, a cAMP-Specific Phosphodiesterase-4 Inhibitor, Reduces Oxidative Stress and Improves Synapse Functions in Human Cortical Neurons Exposed to the Excitotoxin Quinolinic Acid.
Bhat A; Tan V; Heng B; Lovejoy DB; Sakharkar MK; Essa MM; Chidambaram SB; Guillemin GJ
ACS Chem Neurosci; 2020 Dec; 11(24):4405-4415. PubMed ID: 33261317
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
Essam RM; Ahmed LA; Abdelsalam RM; El-Khatib AS
Life Sci; 2019 Apr; 222():245-254. PubMed ID: 30858122
[TBL] [Abstract][Full Text] [Related]
8. Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.
Hasan N; Zameer S; Najmi AK; Parvez S; Yar MS; Akhtar M
Pharmacol Rep; 2021 Oct; 73(5):1287-1302. PubMed ID: 33860460
[TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats.
Farid HA; Sayed RH; El-Shamarka ME; Abdel-Salam OME; El Sayed NS
Inflammopharmacology; 2024 Apr; 32(2):1421-1437. PubMed ID: 37541971
[TBL] [Abstract][Full Text] [Related]
10. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
11. Molecular, histological and behavioral evidences for neuroprotective effects of minocycline against nicotine-induced neurodegeneration and cognition impairment: Possible role of CREB-BDNF signaling pathway.
Motaghinejad M; Farokhi N; Motevalian M; Safari S
Behav Brain Res; 2020 May; 386():112597. PubMed ID: 32198107
[TBL] [Abstract][Full Text] [Related]
12. Suppression of phosphodiesterase IV enzyme by roflumilast ameliorates cognitive dysfunction in aged rats after sevoflurane anaesthesia via PKA-CREB and MEK/ERK pathways.
Liu P; Wang J; Peng S; Zhang D; Zhuang L; Liu C; Zhang Y; Shi X
Eur J Neurosci; 2022 Aug; 56(4):4317-4332. PubMed ID: 35767003
[TBL] [Abstract][Full Text] [Related]
13. Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.
Jabaris SG; Sumathy H; Kumar RS; Narayanan S; Thanikachalam S; Babu CS
Eur J Pharmacol; 2015 Jan; 746():138-47. PubMed ID: 25446433
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 4 Inhibitor Roflumilast Protects Rat Hippocampal Neurons from Sevoflurane Induced Injury via Modulation of MEK/ERK Signaling Pathway.
Peng S; Yan HZ; Liu PR; Shi XW; Liu CL; Liu Q; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2329-2337. PubMed ID: 29550808
[TBL] [Abstract][Full Text] [Related]
15. Curcumin confers neuroprotection against alcohol-induced hippocampal neurodegeneration via CREB-BDNF pathway in rats.
Motaghinejad M; Motevalian M; Fatima S; Hashemi H; Gholami M
Biomed Pharmacother; 2017 Mar; 87():721-740. PubMed ID: 28095363
[TBL] [Abstract][Full Text] [Related]
16. Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
Izikki M; Raffestin B; Klar J; Hatzelmann A; Marx D; Tenor H; Zadigue P; Adnot S; Eddahibi S
J Pharmacol Exp Ther; 2009 Jul; 330(1):54-62. PubMed ID: 19386793
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast, a Phosphodiesterase-4 Inhibitor, Ameliorates Sleep Deprivation-Induced Cognitive Dysfunction in C57BL/6J Mice.
Bhat A; Bishir M; Pandi-Perumal SR; Chang SL; Chidambaram SB
ACS Chem Neurosci; 2022 Jul; 13(13):1938-1947. PubMed ID: 35736514
[TBL] [Abstract][Full Text] [Related]
18. Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
Santiago A; Soares LM; Schepers M; Milani H; Vanmierlo T; Prickaerts J; Weffort de Oliveira RM
Neuropharmacology; 2018 Aug; 138():360-370. PubMed ID: 29933009
[TBL] [Abstract][Full Text] [Related]
19. Roflumilast counteracts DMH-induced preneoplastic colon damage in albino Wistar rats.
Saeedan AS; Rastogi S; Ansari MN
Hum Exp Toxicol; 2020 Nov; 39(11):1545-1555. PubMed ID: 32524861
[TBL] [Abstract][Full Text] [Related]
20. The phosphodiesterase type 4 inhibitor roflumilast suppresses inflammation to improve diabetic bladder dysfunction rats.
Ding H; Zhang P; Li N; Liu Y; Wang P
Int Urol Nephrol; 2019 Feb; 51(2):253-260. PubMed ID: 30474782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
